Effects of the 3M™ MEC Sprayable Pheromone® formulation on gypsy moth mating success

The study was conducted during 2000, 2001, 2003 and 2004 in forested areas in Virginia, USA to evaluate the 3M™ MEC-GM Sprayable Pheromone® formulation of the gypsy moth sex pheromone, disparlure, for its ability to disrupt mating in gypsy moth, Lymantria dispar (Lep.: Lymantriidae). Both mating success of gypsy moth females and male moth catches in pheromone-baited traps were significantly reduced in plots treated with the 3M™ MEC-GM formulation at dosages ranging from 15 to 75 g of active ingredient/ha. However, the 3M™ MEC-GM formulation reduced trap catch to a lesser extent than did the currently registered Hercon Disrupt® II plastic flakes used as a positive control and applied at similar or lower dosages. Furthermore, the effectiveness of the 3M™ sprayable formulation declined through time, so that by the end of the male flight season, male moth catches in traps were significantly higher than in plots treated with Hercon plastic flakes. Based on the reported results, 3M™ MEC-GM Sprayable Pheromone® formulation was never integrated into the operational treatment projects of USDA Forest Service Cooperative Slow-the-Spread of the Gypsy Moth management programme.     

Novel generic UPLC/MS/MS method for high throughput analysis applied to permeability assessment in early Drug Discovery

A novel generic ultra performance liquid chromatography-tandem mass spectrometric (UPLC/MS/MS) method for the high throughput quantification of samples generated during permeability assessment (PAMPA) has been developed and validated. The novel UPLC/MS/MS methodology consists of two stages. Firstly, running a 1.5min isocratic method, compound-specific multiple reaction monitoring (MRM) methods were automatically prepared. In a second stage, samples were analyzed by a 1.5min generic gradient UPLC method on a BEH C18 column (50mmx2.1mm). Compounds were detected with a Waters Micromass Quattro Premier mass spectrometer operating in positive electrospray ionization using the compound-specific MRM methods. The linearity for the validation compounds (caffeine, propranolol, ampicillin, atenolol, griseofulvin and carbamazepine) typically ranges from 3.05nM to 12,500nM and the limits of detection for all generically developed methods are in the range between 0.61nM and 12nM in an aqueous buffer. The novel generic methodology was successfully introduced within early Drug Discovery and resulted in a four-fold increase of throughput as well as a significant increase in sensitivity compared to other in-house generic LC/MS methods.     

Strategies for Understanding and Reducing the Plasmodium vivax and Plasmodium ovale Hypnozoite Reservoir in Papua New Guinean Children: A Randomised Placebo-Controlled Trial and Mathematical Model

Background

The undetectable hypnozoite reservoir for relapsing Plasmodium vivax and P. ovale malarias presents a major challenge for malaria control and elimination in endemic countries. This study aims to directly determine the contribution of relapses to the burden of P. vivax and P. ovale infection, illness, and transmission in Papua New Guinean children.

Methods and Findings

From 17 August 2009 to 20 May 2010, 524 children aged 5–10 y from East Sepik Province in Papua New Guinea (PNG) participated in a randomised double-blind placebo-controlled trial of blood- plus liver-stage drugs (chloroquine [CQ], 3 d; artemether-lumefantrine [AL], 3 d; and primaquine [PQ], 20 d, 10 mg/kg total dose) (261 children) or blood-stage drugs only (CQ, 3 d; AL, 3 d; and placebo [PL], 20 d) (263 children). Participants, study staff, and investigators were blinded to the treatment allocation. Twenty children were excluded during the treatment phase (PQ arm: 14, PL arm: 6), and 504 were followed actively for 9 mo. During the follow-up time, 18 children (PQ arm: 7, PL arm: 11) were lost to follow-up. Main primary and secondary outcome measures were time to first P. vivax infection (by qPCR), time to first clinical episode, force of infection, gametocyte positivity, and time to first P. ovale infection (by PCR). A basic stochastic transmission model was developed to estimate the potential effect of mass drug administration (MDA) for the prevention of recurrent P. vivax infections. Targeting hypnozoites through PQ treatment reduced the risk of having at least one qPCR-detectable P. vivax or P. ovale infection during 8 mo of follow-up (P. vivax: PQ arm 0.63/y versus PL arm 2.62/y, HR = 0.18 [95% CI 0.14, 0.25], p < 0.001; P. ovale: 0.06 versus 0.14, HR = 0.31 [95% CI 0.13, 0.77], p = 0.011) and the risk of having at least one clinical P. vivax episode (HR = 0.25 [95% CI 0.11, 0.61], p = 0.002). PQ also reduced the molecular force of P. vivax blood-stage infection in the first 3 mo of follow-up (PQ arm 1.90/y versus PL arm 7.75/y, incidence rate ratio [IRR] = 0.21 [95% CI 0.15, 0.28], p < 0.001). Children who received PQ were less likely to carry P. vivax gametocytes (IRR = 0.27 [95% CI 0.19, 0.38], p < 0.001). PQ had a comparable effect irrespective of the presence of P. vivax blood-stage infection at the time of treatment (p = 0.14). Modelling revealed that mass screening and treatment with highly sensitive quantitative real-time PCR, or MDA with blood-stage treatment alone, would have only a transient effect on P. vivax transmission levels, while MDA that includes liver-stage treatment is predicted to be a highly effective strategy for P. vivax elimination. The inclusion of a directly observed 20-d treatment regime maximises the efficiency of hypnozoite clearance but limits the generalisability of results to real-world MDA programmes.

Conclusions

These results suggest that relapses cause approximately four of every five P. vivax infections and at least three of every five P. ovale infections in PNG children and are important in sustaining transmission. MDA campaigns combining blood- and liver-stage treatment are predicted to be a highly efficacious intervention for reducing P. vivax and P. ovale transmission.

Trial registration

ClinicalTrials.gov NCT02143934     

Initial effects of the grounding of the tanker Braer on health in Shetland. The Shetland Health Study Group.

OBJECTIVE--To determine if the oil spillage from the tanker Braer had any immediate health effects on the exposed resident population. DESIGN--Cohort study with a comparison against controls, exposure status being assigned on the basis of geographical location. SETTING--Rural Shetland. SUBJECTS--All those resident on or after 5 January 1993 (day 0) within 4.5 km of the site of tanker''s grounding. Controls matched for sex and age were drawn from a general practice list 95 km distant. OUTCOME MEASURES--Demographic details; smoking and alcohol consumption; perception of health and reported presence or absence of specific symptoms; peak expiratory flow; results of haematology, liver and renal function tests, and blood and urine toxicology. RESULTS--Of subjects contacted, 420 (66%) exposed people and 92 (68%) controls were studied; 56 non-attenders were surveyed. Principal health effects arose on days 1 and 2 and were headache, throat irritation, and itchy eyes. No significant differences between those exposed and controls were found for any of the biological markers. Toxicological studies did not show any exposures that are known to affect human health. CONCLUSIONS--The study confirmed the anecdotal reports of certain acute symptoms. No evidence of pulmonary, haematological, renal, or hepatic damage was detected at the population level. Toxicological samples from exposed people did not find levels known to affect human health. Further studies are required to ascertain whether there have been any long term effects on the population.     

Be nimble with threat mitigation: lessons learned from the reintroduction of an endangered species

Reintroductions are increasingly being used to restore species and ecosystems. However, chances of successful establishment are often low. Key to improving success is careful consideration of threats, threat mitigation, monitoring, and subsequent improvement to management. We demonstrate this planning, implementation, and review process using the reintroduction of an endangered mesopredator, the eastern quoll Dasyurus viverrinus, in the first attempt to reestablish it in the wild on mainland Australia. In March 2018, 20 captive‐bred quolls (10 male, 10 female) were released into Booderee National Park and monitored via telemetry, camera, and cage trapping. There were many unknowns and, despite thorough consideration of threats, there were surprising outcomes. Within 3 months, 80% of animals had died; half due to predation, an expected threat. Other threats were unexpected yet, due to good monitoring and responsive management, were quickly detected and effective mitigation implemented. These learnings have been incorporated into revised translocation procedures. One year later, four founder quolls remained and had successfully bred. We highlight lessons applicable to other reintroductions. These are, the importance of: (1) conducting a thorough review of threats and implementing appropriate mitigation; (2) targeted monitoring and responsive management; (3) effective communication, education, and engagement with the local community and stakeholders; and (4) ensuring learnings are disseminated and incorporated into future translocation plans. Threat assessment is an important step in identifying potential reasons for failure. However, actual threats can be realized only via experimentation and monitoring. Applying this knowledge to future reintroduction attempts can increase their chance of success.